(Health-NewsWire.Net, December 06, 2017 ) According to the North America Multiplex Assays Market Research Report, the market is anticipated to grow at a 6.57% CAGR from 2016 to 2021 and it is projected that the North-America market was valued at USD 0.94 billion in 2016 and is anticipated to reach USD 1.29 billion by 2021.
Browse full report @ http://www.marketdataforecast.com/market-reports/north-america-multiplex-assays-market-4998/
While multiplex bead array assays (MBAA) are widely ascribed to be a recent innovation, descriptions of these assays can be found in the literature as far back as 1977. A wide assortment of tests has been devised for MBAA using both immunological and molecular ligands. The potential advantages of these assays are apparent, such as the ability to independently and quantitatively assay multiple analytes simultaneously in small volumes of material and the collection of data from numerous beads for each ligand to provide statistical rigor. The potential cost- and time-savings that could be accrued by use of MBAA in comparison to other methods provides a strong impetus for the routine use of these in both the research and clinical laboratories. As with all clinical laboratory tests, questions of reproducibility, precision, and accuracy must be addressed in order to validate these assays. This commonly involves a comparison to methods considered to be the current standards.
Request sample report @ http://www.marketdataforecast.com/market-reports/north-america-multiplex-assays-market-4998/request-sample
Factors such as increasing number of research & development for treatment of diseases, rising adoption of multiplex assays to reduce operation costs, technological advancements, and growth in adoption of personalized medicine for increasing safety & efficacy of therapies are expected to create new opportunities for the main players during the analysis period. However, lack of experienced healthcare professionals and huge capital investments are the major restrains for the market growth.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-multiplex-assays-market-4998/inquire
This is can be attributed to the increase in the geriatric population, rise in the prevalence of cataract, and rise in the government initiatives to eliminate avoidable blindness. Moreover, rise in adoption of premium lens due to their enhanced visual performance ensures reduced rates of astigmatism, thus boosting the growth of the market. However, unfavorable reimbursement schemes and postoperative complications such as refractive errors are anticipated to have a negative impact on the market growth.
Request discount report @ http://www.marketdataforecast.com/market-reports/north-america-multiplex-assays-market-4998/request-discount
Software and Services
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Nucleic Acid-Based Multiplex Assays
o Planar Nucleic Acid Assays
o Bead-Based Nucleic Acid Assays
Protein-Based Multiplex Assays
o Planar Protein Assays
o Bead-Based Protein Assays
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
Research & Development
o Drug Development
o Biomarker Discovery and Validation
o Infectious Diseases
o Cardiac Diseases
o Autoimmune Diseases
o Alzheimers Disease
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
o Multiplex Planar Arrays
o Multiplex Bead-Based Array
Y-o-Y Growth Analysis, By Technologies
Market Attractiveness Analysis, By Technologies
Market Share Analysis, By Technologies
o End Use
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
Y-o-Y Growth Analysis, By End Use
Market Attractiveness Analysis, By End Use
Market Share Analysis, By End Use
North America Multiplex Assays Market Geography, the market is analyzed under various regions namely U.S. and Canada. North-America accounts for the largest share of the market. The key factors that drive the growth of this market includes increase in pool of patient population, rise in the prevalence of Alzheimer patients, and significant rise in research & development activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimers.
North America Multiplex Assays Industry key players are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and Seegene Inc.
Buy now report @ http://www.marketdataforecast.com/cart/buy-now/north-america-multiplex-assays-market-4998
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast